Anticipate Accounting For Acute Kidney Failure, The Ministry Of Health Asks The Public To Consumption Of Sirop Drugs Equipped With A Doctor's Recipe

Illustration of sirop drugs

In order to prevent cases of acute kidney failure, the Ministry of Health (Kemenkes) urges the public to avoid buying sirop drugs independently without being provided with a prescription from a doctor.

The statement was made by the Head of the Communication and Public Service Bureau of the Indonesian Ministry of Health, Siti Nadia Tarmizi, in response to the emergence of a new case of Assessment of Progresive Acuterines Atypical (GGAPA) in Jakarta.

"The best thing right now is consultation with health workers (nakes). Don't buy your own medicine first," said Siti Nadia, quoted by ANTARA, Monday, February 6.

If the child is sick, he continued, the Ministry of Health recommends being taken to a health care facility to get medicine from a doctor.

"Until now, health care facilities still use puyer drugs," he said.

Siti Nadia said the GGAPA case in children has occurred again in Indonesia. After easing at the end of 2022 and now the case has been identified in DKI Jakarta.

Of the two cases reported by the DKI Health Office, one patient is still a suspect and one confirmed case has died after experiencing complaints of fever and difficulty urinating.

"Patients have a history of taking sirop drugs that are purchased independently," he said.

The fever reduction sirop drug has a Praxion trademark which is purchased from a pharmacy in Jakarta.

Until now, he said, the Ministry of Health and related parties are still investigating the connection between the contamination of the chemical compound Eten Glikol/Diethilen Glikol (EG/DEG) which exceeds the threshold on the raw material for the product, with the case of GGAPA experienced by patients.